Related Experiment Videos
[Aspirin against aging? For whom and how much?]
Therapeutische Umschau. Revue Therapeutique
|August 1, 1990
Summary
Low-dose aspirin can prevent heart attacks and strokes in men over 50 with cardiovascular risks. However, evidence does not support aspirin use for preventing atherosclerosis or clots in healthy individuals.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Preventive Cardiology
Context:
- Aspirin is established for secondary prevention of cardiovascular events.
- Cardiovascular risk factors are prevalent in aging populations.
- Secondary prophylaxis guidelines often include aspirin.
Purpose:
- To evaluate the role of regular aspirin intake in asymptomatic healthy males aged over 50 with cardiovascular risk factors.
- To assess aspirin's efficacy in primary prevention of atherosclerosis and thromboembolic events.
Summary:
- Aspirin is effective in secondary prevention of myocardial infarction, cerebral vascular events, and peripheral arterial disease.
- Regular aspirin intake may offer benefits for asymptomatic men over 50 with cardiovascular risks.
- Current evidence does not support aspirin for primary prevention of atherosclerosis or thromboembolic events in healthy individuals.
Impact:
- Informs clinical guidelines regarding aspirin use in primary versus secondary prevention.
- Highlights the importance of risk stratification for aspirin therapy.
- Suggests a need for further research into aspirin's role in specific asymptomatic populations.